Evidence map›Paper›PMID 22019563›Full record

GuidelineInternational journal of surgery (London, England)2011

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Kenneth F Schulz, Douglas G Altman, David Moher, CONSORT Group

14 registry-linked trialsAbstract readConsensus StatementGuideline
PubMed Publisher
In one paragraph

Guideline in International journal of surgery (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 14 registered trials, which are not on this map. Cited by 473 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
473citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03072082 phase4unknown statusstarted 2017, after this paper: background citation

Study of Curative Effect Evaluation of DanLou Tablet on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy

Ran2017Enrolled440Registered outcomes6Posted comparisons0ConditionsCoronary Artery Disease(CAD)ArmsAspirin Enteric-coated Tablets, Atorvastatin calcium, Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet, Danlou Tablet, DanLou Tablet placebo
PMID 23173251PMID 20432394PMID 20531008PMID 20681275PMID 23303884PMID 26142341PMID 27480425PMID 27491230PMID 27847338other papers from this trial
Open the trial in the graph
NCT03072121 phase4unknown statusstarted 2017, after this paper: background citation

Study of Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy

Ran2017Enrolled440Registered outcomes6Posted comparisons0ConditionsCoronary Artery Disease(CAD)ArmsAspirin Enteric-coated Tablets, Atorvastatin calcium, Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet, Isosorbide Mononitrate Tab 20 MG, Metoprolol Tartrate Tab 25 MG
PMID 27847338PMID 20432394PMID 20531008PMID 20681275PMID 23303884PMID 27480425other papers from this trial
Open the trial in the graph
NCT02029872 phase4completednot on this mapstarted 2014, after this paper: background citation

Stop Community MRSA Colonization Among Patients (SUSTAIN)

TypeinterventionalSponsorJohns Hopkins UniversityRan2014 to 2017Enrolled77ConditionsMRSAArmsChlorhexidine gluconate soap, Chlorhexidine gluconate oral rinse, Mupirocin calcium 2 % ointment
NCT02698371 nacompletednot on this mapstarted 2015, after this paper: background citation

NCCL Direct Composite Restoration Performance With Self-Etch and Multimode Adhesives Clinical Trial

TypeinterventionalSponsorUniversity Fernando PessoaRan2015 to 2018Enrolled38ConditionsDental Adhesives/Restorations PerformanceArmsG1-Control: Futurabond®DC-SE (FBDC_SE), G2-Control: Futurabond®DC_SE_EE, G3: Futurabond® U - ER (FBU_ER), G4: Futurabond® U - SE (FBU_SE), G5: Adhese® Universal - ER (ADU_ER)
NCT03543644 nacompletednot on this mapstarted 2018, after this paper: background citation

A Randomized Controlled Trial of the Effect of Replacing Sugar-sweetened Beverages With Non-nutritive Sweetened Beverages or Water on Gut Microbiome and Metabolic Outcomes: STOP Sugars NOW Trial

TypeinterventionalSponsorUniversity of TorontoRan2018 to 2020Enrolled81ConditionsHealthy, Overweight and Obesity, Metabolic Syndrome, PreDiabetesArmsSugar-sweetened beverage (SSB), Non-nutritive sweetened beverages (NSB), Water
NCT03779698 phase4completednot on this mapstarted 2014, after this paper: background citation

BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars: A 12-Month Randomized Controlled Clinical Trial

TypeinterventionalSponsorKing Abdulaziz UniversityRan2014 to 2016Enrolled37ConditionsDental Caries, PulpotomyArmsBiodentineTM, Formocresol
NCT03873194 nacompletednot on this mapstarted 2019, after this paper: background citation

Use of Meditation as a Complementary Therapy in the Treatment of Gestational Hypertension

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2019 to 2021Enrolled47ConditionsHypertension, Pregnancy-Induced, Hypertension in Pregnancy, HypertensionArmsMeditation, conventional treatment
NCT04080479 nacompletednot on this mapstarted 2019, after this paper: background citation

Bolus Versus Continuous Enteral Feeding in Critically Ill Patients

TypeinterventionalSponsorUniversity Hospital OstravaRan2019 to 2021Enrolled60ConditionsTrauma Injury, Major Abdominal Surgery, SepsisArmsQuadriceps Muscle Layer Fitness, Muscle Strength, Acute Physiology and Chronic Health Evaluation, Sequential Organ Failure Assessment, Nutritional Risk Screening
NCT04229264 phase3unknown statusnot on this mapstarted 2020, after this paper: background citation

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in Subjects With Symptomatic Peripheral Artery Disease (PAD) Undergoing Infrapopliteal Endovascular Peripheral Revascularization Procedures in Patients With Critical Limb

TypeinterventionalSponsorScience Valley Research InstituteRan2020 to 2022Enrolled200ConditionsCritical Limb IschemiaArmsApixaban, ASA, Clopidogrel 75mg
NCT04808531 phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

NanaBis™ an Oro-buccal Administered Equimolar d9-THC & CBD Formulation as Monotherapy for Management of Opioid Requiring Bone Pain Due to Metastatic Cancer: Phase 3 Multi Centre Blinded Randomized Withdrawal Active & Placebo Controlled Trial

TypeinterventionalSponsorMedlab ClinicalRan2023 to 2024Enrolled360ConditionsCancer Related PainArmsNanaBis™, Oxycodone CR, Placebo Spray, Placebo Tablet, Oxycodone IR
NCT06001879 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Protocol Title : Development, Validation, and Evaluation of the Effectiveness of Simulation in Basic Life Support Training (SBLST) on Newly Employed Nurses in Governmental Jordanian Hospitals.

TypeinterventionalSponsoryousef Shukry Mohammad Abu-WardehRan2022 to 2024Enrolled102ConditionsHealthy Nurses, Educational ActivitiesArmsSimulation in basic life support training (SBLST), standard treatment by using an AHA-BLS 2020 brochure
NCT06183320 nacompletednot on this mapstarted 2019, after this paper: background citation

Can Flowable Bulk Fill Composites be Used in Proximal Area of Class II Restorations: A Double-blinded Randomized Clinical Trial

TypeinterventionalSponsorUniversidade Federal FluminenseRan2019 to 2026Enrolled38ConditionsDental Restoration Failure of Marginal IntegrityArmsRestoration with Incremental Composite in Proximal Wall, Restoration with Bulk Fill Composite in Proximal Wall
NCT06906588 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effects of Bilateral Upper Limb Robot-assisted Rehabilitation on Motor Recovery in Patients With Subacute Stroke: an Italian Multicenter Randomized Controlled Trial

TypeinterventionalSponsorIRCCS San Raffaele RomaRan2024 to 2026Enrolled70ConditionsStroke, Sabacute StrokeArmsExperimental, Control
NCT07186322 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Fat Grafting in Upper Limb Burns Scars: a Randomized Clinical Trial

TypeinterventionalSponsorFederal University of São PauloRan2025 to 2026Enrolled40ConditionsAutologous Fat Grafting, Burn, Corticosteroid InjectionArmsFat Graft
3 · Its place in the literature

Who cites it

473 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

413 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kenneth F SchulzFamily Health International, Research Triangle Park, NC 27709, USA. kschulz@fhi.org
Douglas G Altman
David Moher
CONSORT Group

Funding

Canadian Institutes of Health ResearchCancer Research UKMedical Research Council
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Randomized Controlled Trials as TopicResearch DesignResearch Report

Identifiers

PMID22019563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 8 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.